Innovation for a healthier world: How the research-based vaccine manufacturers are contributing to the Decade of vaccines action plan

Press release 30 Jun 2026

WIPO, IFPMA and Interpat join forces to support health innovation through IP management clinics

The World Intellectual Property Organization (WIPO), the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and Interpat have launched a new partnership that underlines a shared commitment to intellectual property supporting health innovation.

Global biopharmaceutical CEOs response to reforms introduced in Germany

On 30 June, in response to reforms introduced in Germany, BCR Secretary General, and IFPMA Director General, Dr. David Reddy, said: “The legislation introduced by the German government undermines the value of medical innovation, global competitiveness and patient access to new medicines. Pricing and reimbursement policies which fail to reflect the value that medicines and...

International data flows: Enabling data-driven, patient-centric innovative pharmaceutical research and development (R&D)

To fulfill the potential of data and new technologies in supporting the shared objective of improving patient lives and population health, it is vital that well-designed systems are put in place.